CMRX
Chimerix Inc
NASDAQ: CMRX · HEALTHCARE · BIOTECHNOLOGY
$8.54
+0.00% today
Updated 2026-04-29
Market cap
$801.08M
P/E ratio
—
P/S ratio
3,778.70x
EPS (TTM)
$-0.99
Dividend yield
—
52W range
$0 – $0
Volume
1.4M
Chimerix Inc (CMRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-43,074.00%
ROE
-56.20%
ROA
-33.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $1.72M | $-25.46M | 100.00% | -1,475.45% | -1,484.37% |
| 2011 | $12.10M | $-25.59M | 100.00% | -206.53% | -211.46% |
| 2012 | $33.72M | $-4.41M | 10.72% | -8.25% | -13.07% |
| 2013 | $4.37M | $-36.45M | -464.35% | -654.90% | -833.98% |
| 2014 | $4.04M | $-59.31M | -1,023.24% | -1,457.08% | -1,468.12% |
| 2015 | $10.76M | $-117.37M | 100.00% | -1,098.78% | -1,090.62% |
| 2016 | $5.70M | $-76.39M | 100.00% | -1,367.10% | -1,339.71% |
| 2017 | $4.49M | $-70.98M | -1,000.31% | -1,604.41% | -1,579.53% |
| 2018 | $7.22M | $-69.47M | -665.51% | -992.31% | -962.78% |
| 2019 | $12.52M | $-173.65M | -207.46% | 108.18% | -1,387.09% |
| 2020 | $5.37M | $-42.13M | 100.00% | -828.67% | -784.18% |
| 2021 | $1.98M | $-255.79M | 76.35% | -8,762.00% | -12,925.47% |
| 2022 | $33.82M | $172.17M | 98.68% | -178.53% | 509.01% |
| 2023 | $324000.00 | $-82.09M | 100.00% | -28,723.77% | -25,337.96% |
| 2024 | $212000.00 | $-88.39M | 100.00% | -45,550.47% | -41,691.98% |